drugset / Trial / NCT04813822

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

NCT04813822

Phase 2 Unknown 90 enrolled Aesculape CRO Belgium BV
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a multicentre, three-arm, double-blind, randomized controlled, parallel-group, comparative phase II clinical trial to evaluate miconazole nitrate 2% + domiphen bromide vaginal cream in subjects with acute vulvovaginal candidiasis.

Timeline

Start
2021-09-13
Primary completion
2022-05
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Domiphen Small molecule Other
Subject Miconazole Small molecule 2 % Other